Flora Tassone Selected Research

5' Untranslated Regions (5' UTR)

1/2022	Both cis and trans-acting genetic factors drive somatic instability in female carriers of the FMR1 premutation.
9/2021	FMRP Levels in Human Peripheral Blood Leukocytes Correlates with Intellectual Disability.
1/2021	Expression of expanded FMR1-CGG repeats alters mitochondrial miRNAs and modulates mitochondrial functions and cell death in cellular model of FXTAS.
4/2019	Molecular Biomarkers in Fragile X Syndrome.
1/2017	Translation of Expanded CGG Repeats into FMRpolyG Is Pathogenic and May Contribute to Fragile X Tremor Ataxia Syndrome.
6/2014	Group I metabotropic glutamate receptor mediated dynamic immune dysfunction in children with fragile X syndrome.
5/2014	CGG allele size somatic mosaicism and methylation in FMR1 premutation alleles.
1/2014	The multiple molecular facets of fragile X-associated tremor/ataxia syndrome.
1/2014	Genomic studies in fragile X premutation carriers.
3/2013	Sequestration of DROSHA and DGCR8 by expanded CGG RNA repeats alters microRNA processing in fragile X-associated tremor/ataxia syndrome.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Flora Tassone Research Topics

Disease

59	Fragile X Tremor Ataxia Syndrome 05/2022 - 07/2004
42	Intellectual Disability (Idiocy) 09/2022 - 12/2002
42	Fragile X Syndrome (Martin Bell Syndrome) 12/2020 - 12/2003
14	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 07/2004
12	Autistic Disorder (Autism) 09/2022 - 11/2008
11	Autism Spectrum Disorder 12/2020 - 07/2012
8	Tremor (Tremors) 12/2020 - 05/2003
5	DiGeorge Syndrome (Syndrome, DiGeorge) 01/2020 - 03/2009
4	Disease Progression 01/2021 - 06/2011
4	Ataxia (Dyssynergia) 05/2020 - 05/2003
3	Neurodevelopmental Disorders 09/2021 - 12/2004
3	Inborn Genetic Diseases (Disease, Hereditary) 12/2020 - 10/2014
3	Mitochondrial Diseases (Mitochondrial Disease) 11/2016 - 12/2010
2	Cognitive Dysfunction 01/2022 - 03/2016
2	Leukoencephalopathies 01/2021 - 06/2015
2	Type 2 Diabetes Mellitus (MODY) 11/2019 - 01/2019
2	Alzheimer Disease (Alzheimer's Disease) 07/2015 - 03/2014
2	Parkinson Disease (Parkinson's Disease) 02/2009 - 07/2007
1	Gait Ataxia 12/2020
1	Glucose Intolerance 11/2019
1	Obesity 11/2019
1	Nervous System Trauma 05/2019
1	Peripheral Nervous System Diseases (PNS Diseases) 05/2019
1	Major Depressive Disorder (Major Depressive Disorders) 11/2018
1	Chronic Pain 11/2018
1	Fibromyalgia (Fibrositis) 11/2018
1	Prodromal Symptoms 01/2018
1	Lyme Disease (Disease, Lyme) 01/2018
1	Neurologic Gait Disorders (Gait, Hemiplegic) 01/2018
1	Pathologic Processes 01/2018
1	Inflammation (Inflammations) 01/2018
1	Seizures (Absence Seizure) 01/2018
1	Flatfoot (Flat Feet) 01/2018
1	Substance-Related Disorders (Drug Abuse) 01/2016
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/2016

Drug/Important Bio-Agent (IBA)

37	Messenger RNA (mRNA)IBA 01/2021 - 01/2003
27	Proteins (Proteins, Gene)FDA Link 12/2020 - 01/2003
18	5' Untranslated Regions (5' UTR)IBA 01/2022 - 12/2002
15	Biomarkers (Surrogate Marker)IBA 05/2022 - 06/2008
12	Fragile X Mental Retardation ProteinIBA 09/2022 - 01/2003
11	RNA (Ribonucleic Acid)IBA 07/2015 - 07/2004
7	UbiquitinIBA 01/2021 - 05/2003
6	DNA (Deoxyribonucleic Acid)IBA 09/2022 - 07/2007
5	ElementsIBA 06/2014 - 12/2003
4	Mitochondrial DNA (mtDNA)IBA 01/2019 - 12/2010
4	Lamin Type A (Lamin A)IBA 01/2012 - 12/2005
3	IronIBA 01/2022 - 12/2018
3	Amyloid (Amyloid Fibrils)IBA 01/2021 - 07/2015
3	MicroRNAs (MicroRNA)IBA 01/2021 - 03/2013
3	Metformin (Glucophage)FDA LinkGeneric 06/2020 - 01/2019
3	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2020 - 06/2017
3	Protein Isoforms (Isoforms)IBA 01/2020 - 11/2017
3	Sertraline (Zoloft)FDA LinkGeneric 01/2020 - 06/2017
3	Pharmaceutical PreparationsIBA 11/2019 - 11/2014
3	Dopamine (Intropin)FDA LinkGeneric 04/2014 - 03/2009
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2021 - 04/2010
2	LipidsIBA 01/2021 - 10/2016
2	gamma-Aminobutyric Acid (GABA)IBA 05/2019 - 08/2017
2	Adenosine Triphosphate (ATP)IBA 01/2019 - 01/2017
2	CytosineIBA 01/2018 - 01/2004
2	GuanineIBA 01/2018 - 01/2004
2	Neurotransmitter Agents (Neurotransmitter)IBA 06/2017 - 11/2016
2	AntioxidantsIBA 10/2016 - 01/2016
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 03/2014 - 05/2013
2	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 01/2014 - 03/2009
2	Minocycline (Cyclops)FDA LinkGeneric 08/2013 - 04/2013
2	Crystallins (Crystallin)IBA 01/2012 - 08/2008
1	tau Proteins (tau Protein)IBA 01/2021
1	N 30IBA 01/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021
1	Sirolimus (Rapamycin)FDA Link 01/2021
1	ApolipoproteinsIBA 01/2021
1	SphingolipidsIBA 01/2021
1	Apolipoproteins E (ApoE)IBA 01/2021
1	Protein Kinases (Protein Kinase)IBA 01/2021
1	Patched-1 ReceptorIBA 12/2020
1	Lovastatin (Mevacor)FDA LinkGeneric 01/2020
1	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2020
1	Pregnanolone (Allopregnanolone)IBA 05/2019
1	NeurosteroidsIBA 05/2019
1	BiguanidesIBA 01/2019
1	AntibodiesIBA 12/2018
1	Indicators and Reagents (Reagents)IBA 12/2018
1	CalciumIBA 12/2018
1	Fentanyl (Sublimaze)FDA LinkGeneric 11/2018
1	Opioid Analgesics (Opioids)IBA 11/2018
1	Hormones (Hormone)IBA 01/2018
1	Dihydrotachysterol (AT 10)IBA 01/2018
1	AMP-Activated Protein KinasesIBA 01/2018
1	EnzymesIBA 01/2018
1	Nonsense Codon (Nonsense Mutation)IBA 01/2018
1	ganaxoloneIBA 08/2017
1	Serotonin (5 Hydroxytryptamine)IBA 06/2017
1	Lactic Acid (Lactate)FDA LinkGeneric 11/2016
1	DisulfidesIBA 10/2016
1	NucleotidesIBA 10/2016
1	Phenobarbital (Luminal)FDA Link 03/2016
1	oleylamide (oleamide)IBA 01/2016

Therapy/Procedure

3	Therapeutics 01/2021 - 12/2011
2	Precision Medicine 05/2019 - 10/2016